These results are in line with a recent study on oropharyngeal cancer in four Catalonian hospitals where double positivity for HPV-DNA/p16 showed the strongest diagnostic biomarker accuracy and prognostic value [47]. This evidence concerns the gene CDKN2A and oropharynx cancer.